Related Experiment Video
Updated: Aug 14, 2026
A Deep-sequencing-assisted, Spontaneous Suppressor Screen in the Fission Yeast Schizosaccharomyces pombe
Published on: March 7, 2019
Inactivity of recombinant ELA2B provides a new example of evolutionary elastase silencing in humans
Edit Szepessy1, Miklós Sahin-Tóth
1Department of Molecular and Cell Biology, Goldman School of Dental Medicine, Boston University, Boston, Mass., USA.
Background:
The archetypal mammalian elastase (ELA1) is not expressed in the human pancreas, because evolutionary mutations suppressed transcription of the ELA1 gene.
Aims:
In this study, we tested the theory that the unique duplication of the ELA2 gene in humans might compensate for the loss of ELA1.
Methods:
Recombinant ELA2A and ELA2B were expressed in Escherichia coli, and their activity was tested on Glt-Ala-Ala-Pro-Leu-p-nitroanilide, DQ elastin and bovine milk protein.
Results:
Surprisingly, recombinant ELA2B was completely devoid of proteolytic activity, while ELA2A readily hydrolyzed all three test substrates. Furthermore, ELA2A formed an SDS-resistant complex with alpha1-antitrypsin, whereas ELA2B did not bind covalently to the inhibitor. Finally, chimeras and point mutations engineered between ELA2A and ELA2B revealed that multiple evolutionary mutations inactivated ELA2B.
Conclusions:
The results indicate that ELA2B is not an elastase enzyme and confirm that ELA2A is the major elastase in the human pancreas.
